About Dr. Aswin - Dr Aswin Liver Expert

About Dr. Aswin Krishna

Dr. Aswin Krishna, MBBS, MD (GEN MED), DM (HEPATOLOGY) is the Consultant of Hepatology. Dr. Aswin is the top hepatologist and leading Transplant physician in Tamil Nadu. After completing his MBBS from Kanyakumari Government Medical College, he obtained his master’s in General Medicine (MD) from Madras Medical College. He then did a Doctorate of Medicine-Hepatology at Madras Medical College and did a Fellowship in liver transplantation at Rela Hospitals, Chennai. He is also an Intuitive certified in Obervership in Liver Transplantation training.

Qualifications

Fellowship in liver transplantation (LTSI Accredited) Rela hospitals, Chennai (October 2022-September 2023)
Doctorate of Medicine-Hepatology (Super specialty postgraduation) Madras Medical College, Dr.M.G.R University, Tamil Nadu, India (September 2019- September 2022)

Doctor of Medicine-General Medicine (Broad specialty postgraduation) Madras Medical College, Dr. M.G.R University, Tamil Nadu, India (May 2015 – May 2018)

Bachelor of Medicine, Bachelor of Surgery Kanyakumari Government Medical College, Dr.M.G.R University, Tamil Nadu, India. (August 2008 – March 2014)

Certificates

Obervership in Liver Transplantation training
Global glengals Health City- Chennai ,India
(February 2022 – April 2022)

Prizes and Bursaries

1. Best paper presented in ISGCON -Remdesvir Induced Hepatotoxicity in COVID Patients

2. Covid warrior award 2020

3. MBBS: Passed with Distinction (75%) in ophthalmology

Papers Published

1. A study on incidence of rhabdomyolysis in liver cirrhosis and their correlation with serum albumin URL: http://repository-tnmgrmu.ac.in/9170/

2. Efficacy of N Acetyl Cysteine in Remdesvir Induced Hepatotoxicity in COVID-19 Patients J Clin Exp Hepatol. 2022; 12: S26–S27.

3. Cardiac evaluation in liver transplantation: journal of experimental hepatology (accepted)

4. Phaeohyphomycosis in liver transplantation: journal of infectious disease (accepted)

5. Ongoing studies(permitted to publish at the end of study by the guide)

a) Screening for hcc in chronic hepatitis b patients

b) spectrum of ACLF in alcoholic hepatitis patients

Involved in ICON STUDY IN NASH

APASL-AARC STUDY

CARS STUDY- NAFLD

Papers Presented Recently

1. ILBS 2023- fungal infections In liver transplant

2. ILBS 2022- Peliosis hepatitis in liver